References
- Nagueh SF. Left ventricular diastolic function: understanding pathophysiology, diagnosis, and prognosis with echocardiography. JACC Cardiovasc Imaging. 2020. 13(1):228–44. doi:https://doi.org/10.1016/j.jcmg.2018.10.038
- Achong N, Wahi S, Marwick TH. 2009. Evolution and outcome of diastolic dysfunction. Heart. 95(10):813–18. doi:https://doi.org/10.1136/hrt.2008.159020.
- Poulter NR, Prabhakaran D, Caulfield M. 2015. Hypertension. Lancet. 386(9995):801–12. doi:https://doi.org/10.1016/S0140-6736(14)61468-9.
- Bountioukos M, Schinkel AF, Bax JJ, Lampropoulos S, Poldermans D. 2006. The impact of hypertension on systolic and diastolic left ventricular function. A tissue Doppler echocardiographic study. Am Heart J. 151(6):1323.e7–12. doi:https://doi.org/10.1016/j.ahj.2006.02.031.
- Sharp AS, Tapp RJ, Thom SA, Francis DP, Hughes AD, Stanton AV, Zambanini A, O’Brien E, Chaturvedi N, Lyons S, et al. ASCOT Investigators. Tissue Doppler E/E’ ratio is a powerful predictor of primary cardiac events in a hypertensive population: an ASCOT substudy. Eur Heart J. 2010;31(6):747–52. doi:https://doi.org/10.1093/eurheartj/ehp498.
- Fici F, Ural D, Tayfun S, Kozdag G, Facchetti R, Brambilla G, Dell’oro R, Grassi G, Mancia G. 2012. Left ventricular diastolic dysfunction in newly diagnosed untreated hypertensive patients. Blood Press. 21(6):331–37. doi:https://doi.org/10.3109/08037051.2012.686179.
- Horio T, Miyazato J, Kamide K, Takiuchi S, Kawano Y, Miyazato J, Kamide K, Takiuchi S, Kawano Y, Kamide K, et al. Influence of low high-density lipoprotein cholesterol on left ventricular hypertrophy and diastolic function in essential hypertension. Am J Hypertens. 2003 Nov;16(11):938–44. doi:https://doi.org/10.1016/s0895-7061(03)01015-x.
- Phillips RA, Coplan NL, Krakoff LR, Yeager K, Ross RS, Gorlin R, Goldman ME. 1987. Doppler echocardiographic analysis of left ventricular filling in treated hypertensive patients. J Am Coll Cardiol. 9(2):317–22. doi:https://doi.org/10.1016/s0735-1097(87)80382-0.
- Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M, Shitrit A, Fuchs ZH. 1985. A link between hypertension obesity and glucose intolerance. J Clin Invest. 75(3):809–17. doi:https://doi.org/10.1172/JCI111776.
- Skarfors ET, Lithell HO, Selinus I. Risk factors for the development of hypertension: a 10-year longitudinal study in middle-aged men. J Hypertens. 1991 Mar;3(3):217–23. doi:https://doi.org/10.1097/00004872-199103000-00004.
- Belke DD, Betuing S, Tuttle MJ, Graveleau C, Young ME, Pham M, Zhang D, Cooksey RC, McClain DA, Litwin SE, et al. Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. J Clin Invest. 2002;109(5):629–39. doi:https://doi.org/10.1172/JCI13946.
- Watanabe K, Sekiya M, Tsuruoka T, Funada J, Kameoka H. Effect of insulin resistance on left ventricular hypertrophy and dysfunction in essential hypertension. J Hypertens 1999 ;17(8):1153–60. doi:https://doi.org/10.1097/00004872-199917080-00015.
- Lind L, Andersson PE, Andrén B, Hänni A, Lithell HO. Left ventricular hypertrophy in hypertension is associated with the insulin resistance metabolic syndrome. J Hypertens. 1995;4:433–38.
- Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. 2008. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 6(4):299–304. doi:https://doi.org/10.1089/met.2008.0034.
- Zheng R, Mao Y. 2017. Triglyceride and glucose (TyG) index as a predictor of incident hypertension: a 9-year longitudinal population-based study. Lipids Health Dis. 16(1):175. doi:https://doi.org/10.1186/s12944-017-0562-y.
- Angoorani P, Heshmat R, Ejtahed HS, Motlagh ME, Ziaodini H, Taheri M, Aminaee T, Goodarzi A, Qorbani M, Kelishadi R. 2018. Validity of triglyceride-glucose index as an indicator for metabolic syndrome in children and adolescents: the CASPIAN-V study. Eat Weight Disord. 23(6):877–83. doi:https://doi.org/10.1007/s40519-018-0488-z.
- Lee SB, Ahn CW, Lee BK, Kang S, Nam JS, You JH, Kim MJ, Kim MK, Park JS. 2018. Association between triglyceride glucose index and arterial stiffness in Korean adults. Cardiovasc Diabetol. 17(1):41. doi:https://doi.org/10.1186/s12933-018-0692-1.
- Park K, Ahn CW, Lee SB, Kang S, Nam JS, Lee BK, Kim JH, Park JS. 2019. Elevated TyG index predicts progression of coronary artery calcification. Diabetes Care. 42(8):1569–73. doi:https://doi.org/10.2337/dc18-1920.
- Sánchez-Íñigo L, Navarro-González D, Fernández-Montero A, Pastrana-Delgado J, Martínez JA. 2016. The TyG index may predict the development of cardiovascular events. Eur J Clin Invest. 46(2):189–97. doi:https://doi.org/10.1111/eci.12583.
- Chiu TH, Tsai HJ, Chiou HC, Wu PY, Huang JC, Chen SC. 2021. A high triglyceride-glucose index is associated with left ventricular dysfunction and atherosclerosis. Int J Med Sci. 18(4):1051–57. doi:https://doi.org/10.7150/ijms.53920.
- Lee TL, Hsuan CF, Wu CC, Hung WC, Tsai IT, Wei CT, Yu TH, Lu IC, Chung FM, Lee YJ, et al. Association between triglyceride glucose index and corrected QT prolongation in Chinese male steelworkers. Int J Environ Res Public Health. 2021;18(8):4020. doi:https://doi.org/10.3390/ijerph18084020.
- American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Obesity Society. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the obesity society. Circulation. 2014;129(25 Suppl 2):102–38. doi:https://doi.org/10.1161/01.cir.0000437739.71477.
- Devereux RB, Reichek N. 1977. Echocardiographic determination of left ventricular mass in man. anatomic validation of the method. Circulation. 55(4):613–18. doi:https://doi.org/10.1161/01.cir.55.4.613.
- Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T, Flachskampf FA, Gillebert TC, Klein AL, Lancellotti P, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the american society of echocardiography and the european association of cardiovascular imaging. J Am Soc Echocardiogr. 2016;29(4):277–314.doi:https://doi.org/10.1016/j.echo.2016.01.011.
- Bigazzi R, Bianchi S, Buoncristiani E, Campese VM. 2008. Increased cardiovascular events in hypertensive patients with insulin resistance: a 13-year follow-up. Nutr Metab Cardiovasc Dis. 18(4):314–19. doi:https://doi.org/10.1016/j.numecd.2006.11.001.
- Cardona-Muñoz EG, Cardona-Müller D, Totsuka-Sutto S, Nuño-Guzmán CM, Pascoe-González S, Romero-Prado M, Miranda-Díaz AG. 2007. Association of hyperinsulinemia with left ventricular hypertrophy and diastolic dysfunction in patients with hypertension. Rev Med Chil. 135(9):1125–31. doi:https://doi.org/10.4067/s0034-98872007000900005.
- Dinh W, Lankisch M, Nickl W, Scheyer D, Scheffold T, Kramer F, Krahn T, Klein RM, Barroso MC, Füth R. Insulin resistance and glycemic abnormalities are associated with deterioration of left ventricular diastolic function: a cross-sectional study. Cardiovasc Diabetol. 2010. 9(1):63. doi:https://doi.org/10.1186/1475-2840-9-63
- Nkum BC, Micah FB, Ankrah TC, Nyan O, Saez ME. 2014. Left ventricular hypertrophy and insulin resistance in adults from an urban community in The Gambia: cross-sectional study. PLoS One. 9(4):e93606. doi:https://doi.org/10.1371/journal.pone.0093606.
- Witteles RM, Fowler MB. 2008. Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options. J Am Coll Cardiol. 51(2):93–102. doi:https://doi.org/10.1016/j.jacc.2007.10.021.
- Jain A, Avendano G, Dharamsey S, Dasmahapatra A, Agarwal R, Reddi A, Regan T. 1996. Left ventricular diastolic function in hypertension and role of plasma glucose and insulin. Comparison with diabetic heart. Circulation. 93(7):1396–402. doi:https://doi.org/10.1161/01.cir.93.7.1396.
- Miyazato J, Horio T, Takishita S, Kawano Y. 2002. Fasting plasma glucose is an independent determinant of left ventricular diastolic dysfunction in nondiabetic patients with treated essential hypertension. Hypertens Res. 25(3):403–09. doi:https://doi.org/10.1291/hypres.25.403.
- Sharp SD, Williams RR. Fasting insulin and left ventricular mass in hypertensive and normotensive controls. Cardiology. 1992;81(4–5):207–21. doi:https://doi.org/10.1159/000175806.
- Verdecchia P, Reboldi G, Schillaci G, Borgioni C, Ciucci A, Telera MP, Santeusanio F, Porcellati C, Brunetti P. Circulating insulin and insulin growth factor-1 are independent determinants ofleft ventricular mass and geometry in essential hypertension. Circulation. 1999;100(17):1802–07. doi:https://doi.org/10.1161/01.CIR.100.17.1802.
- Tsang TS, Barnes ME, Gersh BJ, Bailey KR, Seward JB. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol. 2002;90(12):1284–89.doi:https://doi.org/10.1016/S0002-9149(02)02864-3.
- Shavarova EK, ZhD K, Yezhova NE, Khomova IA, Bazdyreva EI. 2020. Early structural and functional left ventricular disorders in young patients with hypertension: a role of insulin resistance. Russian J Cardio. 25(3):3774. doi:https://doi.org/10.15829/1560-4071-2020-3-3774.
- Taylor D. 2006. Diastolic function: the necessary basics. J Diagn Med Sonogr. 22(2):99–108. doi:https://doi.org/10.1177/8756479306286502.
- Palmiero P, Zito A, Maiello M, Cameli M, Modesti PA, Muiesan ML, Novo S, Saba PS, Scicchitano P, Pedrinelli R, et al. 2015. Left ventricular diastolic function in hypertension: methodological considerations and clinical implications. J Clin Med Res. 7(3):137–44. doi:https://doi.org/10.14740/jocmr2050w.
- Boyer JK, Thanigaraj S, Schechtman KB, Pérez JE. 2004. Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus. Am J Cardiol. 93(7):870–75. doi:https://doi.org/10.1016/j.amjcard.2003.12.026.
- Wang T, Zhong H, Lian G, Cai X, Gong J, Ye C, Xie L. Low-Grade albuminuria is associated with left ventricular hypertrophy and diastolic Dysfunction in patients with hypertension. Kidney Blood Press Res. 2019. 44(4):590–603. doi:https://doi.org/10.1159/000500782
- Nagano N, Nagano M, Yo Y, Liyama K, Higaki J, Mikami H, Ogihara T. Role of glucose intolerance in cardiac diastolic function in essential hypertension. Hypertension. 1994;23(6_pt_2):1002–05. doi:https://doi.org/10.1161/01.HYP.23.6.1002.
- Costa CH, Batista MC, Moises VA, Kohlmann NB, Ribeiro AB, Zanella MT. 1995. Serum insulin levels, 24-hour blood pressure profile, and left ventricular mass in nonobese hypertensive patients. Hypertension. 26(6):1085–88. doi:https://doi.org/10.1161/01.hyp.26.6.1085.